<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(3)</volume><submitter>Nelli F</submitter><journal>Annals of oncology : official journal of the European Society for Medical Oncology</journal><pagination>352-354</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8660134</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study.</pubmed_title><pmcid>PMC8660134</pmcid><pubmed_authors>Virtuoso A</pubmed_authors><pubmed_authors>Giron Berrios JR</pubmed_authors><pubmed_authors>Cercola P</pubmed_authors><pubmed_authors>Signorelli C</pubmed_authors><pubmed_authors>Chilelli MG</pubmed_authors><pubmed_authors>Silvestri MA</pubmed_authors><pubmed_authors>Giannarelli D</pubmed_authors><pubmed_authors>Pessina G</pubmed_authors><pubmed_authors>Onorato A</pubmed_authors><pubmed_authors>Schirripa M</pubmed_authors><pubmed_authors>Fabbri A</pubmed_authors><pubmed_authors>Marrucci E</pubmed_authors><pubmed_authors>Ruggeri EM</pubmed_authors><pubmed_authors>Nelli F</pubmed_authors><pubmed_authors>Mazzotta M</pubmed_authors><pubmed_authors>Panichi V</pubmed_authors><pubmed_authors>Primi F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study.</name><description/><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2024-11-20T16:58:53.128Z</modification><creation>2022-02-11T13:36:37.702Z</creation></dates><accession>S-EPMC8660134</accession><cross_references><pubmed>34896598</pubmed><doi>10.1016/j.annonc.2021.12.001</doi></cross_references></HashMap>